Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin
Clinical trial NCT03798080 · COMPLETED
Trial details
- NCT number
- NCT03798080
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2020-12-01
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.